Full Program »
Measures and Countermeasures: How to Evaluate Attempts to Address Funding BiasI argue that industry-funded areas of science are best conceived of as an "asymmetric arms race." Such a dynamic is typified by a series of moves and countermoves between competing parties. In the case of regulation (government or private) of industry-funded science, this dynamic occurs between those who seek to make practice more responsive to good evidence and those whose primary motivations are instead commercial in character. I explore the FDA’s recent approval of Flibanserin (popularized as “the female viagra”) as an example of this dynamic and then elaborate how the arms race picture changes how to evaluate science/regulatory policy.
Underwood International College